ALIVE is a pioneering mid-to-late stage HealthTech fund based in Israel, dedicated to accelerating the growth of innovative healthcare technologies. By leveraging an exclusive ecosystem of strategic partners—including leading hospital chains, health maintenance organizations (HMOs), and financial institutions—ALIVE supports portfolio companies in their clinical and commercial expansion. This collaborative approach enables ALIVE to deliver a capital-efficient model for HealthTech investors, offering high rewards with relatively low

over a condensed investment journey of 3-5 years.

The fund focuses on companies with the highest potential to improve the quality of life for millions of people, emphasizing in-depth understanding of clinical workflows, proven hands-on guidance, and product-market fit validation under challenging health economics and evolving market trends.